Anne-Sophie Bargnoux1,2, Fernando Vetromile3, Nils Kuster1,2, Julie Barberet1, Anne-Marie Dupuy1, Jean Ribstein4, Georges Mourad3, Jean-Paul Cristol5,6,7, Pierre Fesler4. 1. Laboratoire de Biochimie, CHRU Montpellier, Univ Montpellier 1, Montpellier, France. 2. PhyMedExp, University of Montpellier, INSERM U1046, CNRS UMR 9214, 34295, Montpellier Cedex 5, France. 3. Service de Néphrologie et Transplantation, CHRU Montpellier, Univ Montpellier 1, Montpellier, France. 4. Service de Médecine Interne, CHRU Montpellier, Univ Montpellier 1, Montpellier, France. 5. Laboratoire de Biochimie, CHRU Montpellier, Univ Montpellier 1, Montpellier, France. jp-cristol@chu-montpellier.fr. 6. PhyMedExp, University of Montpellier, INSERM U1046, CNRS UMR 9214, 34295, Montpellier Cedex 5, France. jp-cristol@chu-montpellier.fr. 7. Department of Biochemistry, Lapeyronie University Hospital, 191 Avenue du Doyen Gaston Giraud, 34295, Montpellier Cedex 5, France. jp-cristol@chu-montpellier.fr.
Abstract
BACKGROUND: Bone-vessel interaction in chronic renal failure remains poorly understood and could be driven by bone remodeling factors including osteoprotegerin (OPG), fibroblast growth factor 23 (FGF23), parathormone and vitamin D. Only few data are available in renal transplantation. The aim of this study was to investigate the relationship between bone remodeling factors and large artery function in renal transplant patients. METHODS: 89 renal transplant patients were enrolled in this cross-sectional study. Carotid to femoral pulse wave velocity (PWV) and central augmentation index (AIx) were determined as an estimation of large artery function. Blood samples were collected for measurement of vascular risk markers. Independent predictors were identified by multivariate linear regression through backward feature selection using Akaike's information criteria. RESULTS: At multivariate analysis, age (p < 0.001) and systolic arterial pressure (p = 0.003) were significantly associated with PWV but not AIx. In addition, both elevated blood concentrations of 1.25(OH)2 vitamin D (p = 0.013) and OPG (p = 0.047) were still significantly related to high PWV. CONCLUSIONS: These results underline that age and mean arterial pressure are the main determinants of PWV following renal transplantation. Among bone remodeling biomarkers, plasma OPG and active vitamin D were the strongest determinants of arterial stiffness.
BACKGROUND: Bone-vessel interaction in chronic renal failure remains poorly understood and could be driven by bone remodeling factors including osteoprotegerin (OPG), fibroblast growth factor 23 (FGF23), parathormone and vitamin D. Only few data are available in renal transplantation. The aim of this study was to investigate the relationship between bone remodeling factors and large artery function in renal transplant patients. METHODS: 89 renal transplant patients were enrolled in this cross-sectional study. Carotid to femoral pulse wave velocity (PWV) and central augmentation index (AIx) were determined as an estimation of large artery function. Blood samples were collected for measurement of vascular risk markers. Independent predictors were identified by multivariate linear regression through backward feature selection using Akaike's information criteria. RESULTS: At multivariate analysis, age (p < 0.001) and systolic arterial pressure (p = 0.003) were significantly associated with PWV but not AIx. In addition, both elevated blood concentrations of 1.25(OH)2 vitamin D (p = 0.013) and OPG (p = 0.047) were still significantly related to high PWV. CONCLUSIONS: These results underline that age and mean arterial pressure are the main determinants of PWV following renal transplantation. Among bone remodeling biomarkers, plasma OPG and active vitamin D were the strongest determinants of arterial stiffness.
Entities:
Keywords:
Arterial stiffness; Osteoprotegerin; Renal transplantation; Vitamin D
Authors: Barbara Toffoli; Raelene J Pickering; Despina Tsorotes; Bo Wang; Stella Bernardi; Phillip Kantharidis; Bruno Fabris; Giorgio Zauli; Paola Secchiero; Merlin C Thomas Journal: Atherosclerosis Date: 2011-05-27 Impact factor: 5.162
Authors: F Vincenti; S Friman; E Scheuermann; L Rostaing; T Jenssen; J M Campistol; K Uchida; M D Pescovitz; P Marchetti; M Tuncer; F Citterio; A Wiecek; S Chadban; M El-Shahawy; K Budde; N Goto Journal: Am J Transplant Date: 2007-03-12 Impact factor: 8.086
Authors: A-S Bargnoux; A-M Dupuy; V Garrigue; I Jaussent; G Gahide; S Badiou; I Szwarc; S Deleuze; H Vernhet; J-P Cristol; G Mourad Journal: Am J Transplant Date: 2009-09-22 Impact factor: 8.086
Authors: Marc M H Hermans; Ronald Henry; Jacqueline M Dekker; Jeroen P Kooman; Piet J Kostense; Giel Nijpels; Robert J Heine; Coen D A Stehouwer Journal: J Am Soc Nephrol Date: 2007-04-25 Impact factor: 10.121
Authors: David Sengstock; Robin L Sands; Brenda W Gillespie; Xiaotong Zhang; Margaret Kiser; George Eisele; Peter Vaitkevicius; Martin Kuhlmann; Nathan W Levin; Alan Hinderliter; Sanjay Rajagopalan; Rajiv Saran Journal: Nephrol Dial Transplant Date: 2009-10-23 Impact factor: 5.992
Authors: Terence M Doherty; Lorraine A Fitzpatrick; Daisuke Inoue; Jian-Hua Qiao; Michael C Fishbein; Robert C Detrano; Prediman K Shah; Tripathi B Rajavashisth Journal: Endocr Rev Date: 2004-08 Impact factor: 19.871
Authors: Juan C Ramirez-Sandoval; Mauricio Arvizu-Hernandez; Cristino Cruz; Barbara Vazquez-Cantu; Luis J Rojas-Concha; Luis Tamez; Fagundo Reynerio; F Enrique Gomez; Ricardo Correa-Rotter Journal: J Nephrol Date: 2019-03-19 Impact factor: 3.902